Mainsail Partners Invests in Bio-Optronics

We represented Mainsail Partners in its $30 million growth equity investment in Bio-Optronics. Bio-Optronics will use the capital and Mainsail’s support to accelerate product development, enhance customer service, and grow sales and marketing.

Bio-Optronics is a leading software and services company that creates user-focused applications for healthcare organizations that positively impact business performance.

Mainsail Partners is a San Francisco-based growth equity firm that invests in bootstrapped software companies.

You Also May Be Interested In:

  • Represented Pace Payment Systems, Inc. in its sale to i3 Verticals, Inc. for $52.7 million

    We represented Pace Payment Systems, Inc. in its sale to i3 Verticals, Inc. for $52.7 million, plus an earnout payment...
    Client Type: Private Company
  • Represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation’s Naval Systems Business Unit, including its Canadian business and a small number of related contract operations, for $225 million. The acquisition, subject to regulatory approvals, is expected to close in the second half of 2019.┬áSerco Inc., a provider of professional, technology, and management services, will strengthen its presence in naval support with this acquisition, and will become a stronger integrated maritime solutions provider for the U.S Navy and other customers.

    We represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation's Naval Systems Business...
    Client Type: Private Company
  • Represented C-III Capital Partners in its sale of California-based tech company Real Capital Markets (RCM) to LightBox

    We represented C-III Capital Partners, a fully-diversified asset management and commercial real estate services company, in its sale of California-based...
    Client Type: Private Company